Monoclonal antibodies in multiple myeloma

Bookmark and Share
Published: 1 Nov 2016
Views: 1965
Dr Phillippe Moreau - University Hospital of Nantes, Nantes, France

Dr Moreau talks to ecancertv at ICMM 2016 about trials looking at monoclonal antibodies targeting CD38.

In particular, he discusses daratumumab as a promising drug for multiple myeloma.

ecancer's filming at ICMM 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content